By Mill Chart
Last update: Sep 26, 2023
A possible breakout setup was detected on BOSTON SCIENTIFIC CORP (NYSE:BSX) by our stockscreener. A breakout pattern is formed when a stock consolidates after a strong rise up. We note that this pattern is detected purely based on technical analysis and whether the breakout actually materializes remains to be seen. It could be interesting to keep an eye on NYSE:BSX.
As part of its analysis, ChartMill provides a comprehensive Technical Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various technical indicators and properties.
Taking everything into account, BSX scores 9 out of 10 in our technical rating. Both in the recent history as in the last year, BSX has proven to be a steady performer, scoring decent points in every aspect analyzed.
Check the latest full technical report of BSX for a complete technical analysis.
Besides the Technical Rating, ChartMill assigns a Setup Rating to every stock to determine the degree of consolidation. This rating, ranging from 0 to 10, is updated daily and evaluates various short-term technical indicators. NYSE:BSX currently holds a 8 as its setup rating, suggesting a particular level of consolidation in the stock.
Besides having an excellent technical rating, BSX also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is a support zone below the current price at 53.77, a Stop Loss order could be placed below this zone. Another positive sign is the recent Pocket Pivot signal.
A breakout could materialize when the stock breaks out to new highs above the current consolidation zone. One could wait for this to happen and buy when this happens. A stop loss could be placed below the consolidation zone.
Disclaimer: This article is not intended to provide trading advice. It is crucial to conduct your own analysis and consider your own observations and trading style when making investment decisions. The article solely presents technical observations and should not be relied upon as a sole basis for trading.
Our Breakout screener lists more breakout setups and is updated daily.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
BOSTON SCIENTIFIC CORP
NYSE:BSX (12/8/2023, 7:04:01 PM)After market: 54.95 0 (0%)
In-Depth Technical Analysis of BOSTON SCIENTIFIC CORP.
Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending
Wolfe Research downgraded Edwards Lifesciences (EW) to Underperform from Peer Perform, setting its expectations below consensus on emerging competition. Read more here.
The drug is on track to cause massive competitive shifts in the healthcare sector.
Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations.
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the...
Stryker also has a healthy B+ Accumulation/Distribution Rating, showing big investors like mutual funds are fairly heavy buyers of its stock.
MedTech stocks rally after Novo Nordisk (NVO) disappoints with Phase 3 cardiovascular data for its weight loss therapy, Wegovy. Read more here.